Clinical Trials Browser

Breast Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Advanced Breast Cancer

Breast Neoplasms

Breast Neoplasms

Low Grade Serous Ovarian Cancer

Breast Neoplasms, Breast Neoplasms, Male

Breast Neoplasms

Neoplasm Metastasis, Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site

Breast Neoplasms, Neoplasms

Breast Neoplasms, Neoplasms

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Site, Skin Diseases

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Advanced Metastatic Breast Cancer

Advanced Breast Cancer

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms, Neoplasms

Breast Neoplasms, Neoplasms, Recurrence

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Advanced Breast Cancer

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Breast Neoplasms

Quality of Life

Breast Neoplasms

Bone Density

Advanced Breast Cancer

Clinical Trials

Clinical Study on Adjuvant Therapy of TQB3616 Combined With Endocrine Therapy Compared With Placebo Combined With Endocrine Therapy in Patients With Breast Cancer

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

EvoPAR-BR01

CAMBRIA-1

EMBER-4

RAMP 301

ELEGANT

OPERA-01

FALCON

MONARCH plus

MONARCH 3

A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer

SERENA-6

OVELIA

Safety Extension Study for Subjects With HR+, HER2- Breast Cancer for Subjects Who Have Completed the OVELIA Study

SERENA-4

EMERALD

A Study of XZP-3287 in Combination With Letrozole/Anastrozole in Patients With Advanced Breast Cancer

CAMBRIA-2

MONALEESA-7

A Study of SHR6390 in Combination With Letrozole or Anastrozole in Patients With HR Positive and HER2 Negative Advanced Breast Cancer

SALSA

FACE

A Study to Evaluate the Efficacy and Safety of Herceptin® (Trastuzumab) in Combination With Arimidex® (Anastrozole) an Aromatase Inhibitor Compared to Arimidex® Alone in Patients With Metastatic Breast Cancer

ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.

Arimidex/Tamoxifen Neo Adjuvant Study in Premenopausal Patients With Breast Cancer Under Anti Hormonal Treatment

FACT

ATAC - Arimidex, Tamoxifen Alone or in Combination

Aromasin Vs Arimidex Study As Initial Hormonal Therapy In Postmenopausal Women With Advanced/Recurrent Breast Cancer

Study of Faslodex With or Without Concomitant Arimidex Versus Exemestane Following Progression on Non-steroidal Aromatase Inhibitors (NSAI)

Faslodex Advanced Breast Cancer Local Chinese Study

PROACT - Pre-Operative Arimidex Compared To Tamoxifen

ATAC - Pharmacokinetics (PK) Sub-Protocol

ITA - Clinical Study Comparing ARIMIDEX™ With NOLVADEX™ in Women With Breast Cancer Treated With NOLVADEX for at Least 2 Years

3 Years of Anastrozole vs. no Treatment as Extended Adjuvant Therapy for Postmenopausal Women With Breast Cancer

ATAC - Quality of Life Sub-Protocol

ATAC - Endometrial Sub-Protocol

ATAC - Bone Density Sub-Protocol

Second Line Breast Cancer Trial